this is what I am thinking: -Revenue is around $30k a sale as has been shown to be the case from first 3 sales. -So that means that even 40 doses is over a $1.2 million revenue. -Now if baseline costs someone pointed out above are accurate then around that point the company is probably breaking even and even moving into possible profit. - They sold 3 doses in the first quarter they were able to sell & to a population they had access to of maybe 2 million people... - Shortly they should gain access to a population of about 80 million people to sell to with much more to come likely each following quarter for a while. - Even if they do 2 times worse by proportion over the year, not even the quarter, which is unlikely due to spreading the word being their focus at the moment they are likely to get 60 sales this year...
OSL Price at posting:
9.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)